U.S. Commercial Metals, M&T Bank, Simon Property
Sept 3 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Commercial Metals, M&T Bank Corp and Simon Property Group, on Tuesday.
HIGHLIGHTS
* Autodesk Inc ADSK.O: Citigroup raises target price to $325 from $316 |
* Builders Firstsource BLDR.N: Oppenheimer raises target price to $205 from $190 |
* Commercial Metals Co CMC.N: Jefferies initiates with buy rating; price target $65 |
* M&T Bank Corp MTB.N: JP Morgan raises to overweight from neutral |
* Simon Property Group Inc SPG.N: Piper Sandler cuts to neutral from overweight |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 10X Genomics TXG.O: Leerink Partners initiates coverage with outperform rating; PT $35 |
* Abercrombie & Fitch Co ANF.N: Jefferies raises target price to $220 from $215 |
* Adapthealth Corp AHCO.O: Jefferies raises target price to $10.50 from $9.50 |
* Aflac Inc AFL.N: Jefferies raises target price to $97 from $88 |
* Allegro Microsystems Inc ALGM.O: UBS initiates coverage with buy rating and PT $33 |
* Allstate Corp ALL.N: TD Cowen raises target price to $224 from $193 |
* Ally Financial Inc ALLY.N: Goldman Sachs removes stock from its US conviction list |
* Alphabet Inc GOOGL.O: Morgan Stanley cuts target price to $190 from $205 |
* American Healthcare REIT AHR.N: Truist Securities raises PT to $22 from $17 |
* Ameriprise Financial Inc AMP.N: Jefferies raises target price to $511 from $506 |
* Applied Optoelectronics AAOI.O: Raymond James raises to outperform from market perform |
* Arrowhead Pharmaceuticals ARWR.O: Leerink Partners raises PT to $20 from $19 |
* Autodesk Inc ADSK.O: Citigroup raises target price to $325 from $316 |
* Axsome Therapeutics AXSM.O: Wells Fargo initiates coverage with overweight rating and PT $140 |
* Boeing BA.N: Wells Fargo cuts target price to $119 from $185 |
* Boeing BA.N: Wells Fargo cuts to underweight from equal weight |
* Brown-Forman Corp BFb.N: Roth MKM cuts target price to $48 from $49 |
* Builders Firstsource BLDR.N: Oppenheimer raises target price to $205 from $190 |
* Burlington Stores Inc BURL.N: UBS raises target price to $270 from $238 |
* BXP Inc BXP.N: Piper Sandler raises target price to $78 from $70 |
* Ciena Corp CIEN.N: JP Morgan raises target price to $65 from $60 |
* Ciena Corp CIEN.N: Stifel raises target price to $68 from $62 |
* Cinemark Holdings Inc CNK.N: Wedbush raises target price to $31 from $28 |
* Clean Energy Fuels Corp CLNE.O: Scotiabank raises target price to $6 from $5 |
* CME Group Inc CME.O: BofA Global Research cuts price objective to $177 from $212 |
* CME Group Inc CME.O: BofA Global Research cuts to underperform from neutral |
* CNO Financial Group Inc CNO.N: Jefferies raises target price to $31 from $29 |
* Cogent Biosciences Inc COGT.O: Wedbush raises target price to $11 from $10 |
* Commercial Metals Co CMC.N: Jefferies initiates with buy rating; price target $65 |
* Conagra Brands Inc CAG.N: Goldman Sachs adds stock to its US conviction list |
* Core & Main Inc CNM.N: JP Morgan cuts target price to $52 from $54 |
* Corebridge Financial Inc CRBG.N: Jefferies raises target price to $39 from $37 |
* Crowdstrike CRWD.O: Deutsche Bank raises target price to $285 from $275 |
* Dave & Buster'S Entertainment Inc PLAY.O: UBS cuts target price to $35 from $56 |
* Deckers Brands DECK.N: Wedbush removes stock from its best ideas list |
* Delek US Holdings Inc DK.N: Wells Fargo raises target price to $21 from $20 |
* Dick's Sporting Goods Inc DKS.N: TD Cowen raises target price to $270 from $266 |
* Dollar General Corp DG.N: Goldman Sachs removes stock from its US conviction list |
* Dollar General Corporation DG.N: Barclays cuts target price to $102 from $154 |
* Envoy Medical Inc COCH.O: Ascendiant Capital Markets raises PT to $8.75 from $8.50 |
* Eve Holding Inc EVEX.N: H.C. Wainwright initiates coverage with buy rating; PT $6 |
* Factset FDS.N: Deutsche Bank cuts target price to $454 from $461 |
* Foghorn Therapeutics FHTX.O: Jefferies initiates coverage with buy rating; PT $18 |
* Forge Global Holdings Inc FRGE.N: UBS raises to buy from neutral - |
* Glaukos Corp GKOS.N: Stifel raises target price to $145 from $130 |
* Globe Life Inc GL.N: Jefferies raises target price to $95 from $90 |
* Green Plains Inc GPRE.O: Jefferies cuts target price to $28 from $37 |
* Hannon Armstrong HASI.N: RBC initiates coverage with outperform rating |
* Hannon Armstrong HASI.N: RBC initiates coverage with PT $41 |
* HCA Healthcare HCA.N: Deutsche Bank raises target price to $441 from $375 |
* HCA Healthcare HCA.N: Jefferies raises target price to $455 from $390 |
* HF Sinclair Corporation DINO.N: Wells Fargo cuts target price to $54 from $60 |
* IBM IBM.N: Goldman Sachs adds stock to its US conviction list |
* Inari Medical NARI.O: Leerink Partners initiates coverage with market perform rating; PT $47 |
* Insmed Inc INSM.O: Goldman Sachs adds stock to its US conviction list |
* Installed Building Products IBP.N: Goldman Sachs removes stock from its US conviction list |
* International Flavors & Fragrances IFF.N: Mizuho raises PT to $120 from $109 |
* International Flavors & Fragrances IFF.N: Mizuho raises to outperform from neutral |
* Jabil Inc JBL.N: JP Morgan cuts target price to $133 from $137 |
* Jackson Financial Inc JXN.N: Jefferies raises target price to $78 from $74 |
* Joby Aviation Inc JOBY.N: H.C. Wainwright initiates coverage with buy rating; PT $9 |
* Kite Realty Group Trust KRG.N: Piper Sandler raises target price to $33 from $30 |
* Lifeway Foods Inc LWAY.O: Noble Capital raises target price to $25 from $20 |
* Lincoln National Corp LNC.N: Jefferies raises target price to $40 from $38 |
* M&T Bank Corp MTB.N: JP Morgan raises target price to $215 from $183 |
* M&T Bank Corp MTB.N: JP Morgan raises to overweight from neutral |
* Macerich Co MAC.N: Piper Sandler raises target price to $14 from $11 |
* Medical Properties Trust Inc MPW.N: RBC cuts target price to $4 from $5 |
* Metlife Inc MET.N: Jefferies raises target price to $89 from $81 |
* Mongodb Inc MDB.O: Citigroup raises target price to $400 from $350 |
* Montauk Renewables MNTK.O: Scotiabank cuts target price to $6 from $8 |
* Montauk Renewables MNTK.O: Scotiabank cuts to sector perform from sector outperform |
* Motorola MSI.N: Jefferies raises target price to $510 from $460 |
* National Health Investors Inc NHI.N: Truist Securities raises PT to $78 from $65 |
* nCino Inc NCNO.O: Raymond James raises to outperform from market perform |
* Newmark Group Inc NMRK.O: Piper Sandler raises target price to $17 from $13 |
* Nextera Energy Inc NEE.N: Wells Fargo raises target price to $102 from $95 |
* Nucana Plc NCNA.O: Oppenheimer cuts target price to $25 from $150 |
* Okta OKTA.O: Deutsche Bank cuts target price to $115 from $125 |
* Olin Corp OLN.N: BMO initiates coverage with market perform rating; target price $50 |
* ONEOK Inc OKE.N: Citigroup raises target price to $102 from $85 |
* Opal Fuels Inc OPAL.O: Scotiabank cuts target price to $5 from $8 |
* Opal Fuels Inc OPAL.O: Scotiabank cuts to sector perform from sector outperform |
* PBF Energy Inc PBF.N: Wells Fargo cuts target price to $51 from $52 |
* Penumbra PEN.N: Leerink Partners initiates coverage with outperform rating; PT $263 |
* Procept Biorobotics Corp PRCT.O: Truist Securities raises PT to $95 from $74 |
* Progressive Corp PGR.N: BofA Global Research raises price objective to $312 from $294 |
* Progressive Corp PGR.N: KBW raises target price to $275 from $255 |
* Prudential Financial Inc PRU.N: Jefferies raises target price to $140 from $132 |
* Recursion Pharmaceuticals Inc RXRX.O: Leerink Partners cuts PT to $8 from $9 |
* Reinsurance Group of America Inc RGA.N: Jefferies raises PT to $268 from $253 |
* Royal Caribbean Group RCL.N: Goldman Sachs removes stock from its US conviction list |
* Sable Offshore Corp SOC.N: TD Cowen raises target price to $26 from $20 |
* Simon Property Group Inc SPG.N: Piper Sandler cuts target price to $175 from $190 |
* Simon Property Group Inc SPG.N: Piper Sandler cuts to neutral from overweight |
* Soho House & Co SHCO.N: Morgan Stanley resumes with equal-weight rating; PT $5.50 |
* Soleno Therapeutics SLNO.O: H.C. Wainwright initiates coverage with buy rating and PT $70 |
* Sotherly Hotels Inc SOHO.O: Piper Sandler cuts target price to $1.50 from $2 |
* Southwest Airlines Co LUV.N: Evercore ISI raises target price to $35 from $30 |
* Southwest Airlines Co LUV.N: Evercore ISI raises to outperform from in line |
* Sphere Entertainment Co SPHR.N: Benchmark cuts to sell |
* Sprinklr Inc CXM.N: Rosenblatt Securities cuts target price to $11 from $14 |
* Steel Dynamics Inc STLD.O: UBS raises target price to $145 from $129 |
* Steel Dynamics Inc STLD.O: UBS raises to buy from neutral |
* Tenable Holdings Inc TENB.O: Wedbush removes stock from its best ideas list |
* Unity Software Inc U.N: Morgan Stanley raises to overweight from equal-weight |
* Unum Group UNM.N: Jefferies raises target price to $67 from $6 |
* Valero Energy Corp. VLO.N: Wells Fargo raises target price to $172 from $165 |
* Vaxcyte Inc PCVX.O: Jefferies raises target price to $129 from $108 |
* Veeva Systems Inc VEEV.N: Truist Securities raises target price to $207 from $197 |
* Vera Therapeutics Inc VERA.O: JP Morgan raises target price to $72 from $62 |
* Walgreens WBA.O: Leerink Partners cuts target price to $9 from $11 |
* Westlake Corp WLK.N: BMO assumes coverage with market perform rating; PT $171 |
* Willdan Group WLDN.O: Wedbush assumes coverage with outperform rating; PT $51 vs $35 |
* Xylem Inc XYL.N: TD Cowen cuts to hold from buy |
(Compiled by Bengaluru Newsroom)
</body></html>
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
